Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
An announcement from DENTSPLY SIRONA ( (XRAY) ) is now available.
On October 2, 2025, DENTSPLY SIRONA announced that Richard C. Rosenzweig will transition from his role as Executive Vice President, Corporate Development, General Counsel, and Secretary to a non-executive position as Special Legal Advisor, effective October 3, 2025. This transition is part of a mutual agreement, and Mr. Rosenzweig will continue to serve in an advisory capacity until March 4, 2026, with a monthly fee and additional severance benefits, before becoming an independent contractor consultant for a year.
The most recent analyst rating on (XRAY) stock is a Hold with a $16.00 price target. To see the full list of analyst forecasts on DENTSPLY SIRONA stock, see the XRAY Stock Forecast page.
Spark’s Take on XRAY Stock
According to Spark, TipRanks’ AI Analyst, XRAY is a Neutral.
DENTSPLY SIRONA’s overall stock score reflects significant financial challenges, with declining revenues and profitability weighing heavily. Technical indicators suggest a bearish trend, and valuation concerns persist due to negative earnings. However, the earnings call provided some positive insights into operational improvements, and recent corporate events may enhance strategic positioning.
To see Spark’s full report on XRAY stock, click here.
More about DENTSPLY SIRONA
DENTSPLY SIRONA Inc. operates in the dental industry, providing a wide range of dental products and technologies, including dental equipment and consumables, with a focus on innovation and improving dental care.
Average Trading Volume: 3,329,952
Technical Sentiment Signal: Sell
Current Market Cap: $2.58B
See more insights into XRAY stock on TipRanks’ Stock Analysis page.